BATS:NURE Nuveen Short-Term REIT ETF (NURE) Price, Holdings, & News $28.50 +0.29 (+1.02%) Closing price 03:57 PM EasternExtended Trading$28.50 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock About Nuveen Short-Term REIT ETF (BATS:NURE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NURE alerts:Sign Up Key Stats Today's Range$28.03▼$28.2550-Day Range$28.03▼$30.5552-Week Range$26.06▼$35.14Volume2,453 shsAverage Volume7,227 shsMarket Capitalization$35.63 millionAssets Under Management$34.40 millionDividend Yield4.39%Net Expense Ratio0.35%Aggregate RatingHold ETF Overview The Nuveen Short-Term REIT ETF (NURE) is an exchange-traded fund that mostly invests in real estate equity. The fund tracks an index composed of U.S. REITs that typically have shorter-term lease durations than average. NURE was launched on Dec 19, 2016 and is managed by Nuveen. Read More Nuveen Short-Term REIT ETF ExpensesTypeNUREReal Estate ETFsReal Estate ETFsBATS ETFsAll ETFsManagement Fee0.35%0.49%0.42%0.57%0.53%Other Expenses0.00%0.48%0.15%0.48%0.56%Total Expense0.35%0.63%0.47%0.71%0.73%Fee Waiver0.00%-0.58%-0.08%-0.46%-0.63%Net Expense0.35%0.51%0.46%0.64%0.60% Receive NURE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nuveen Short-Term REIT ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address NURE ETF News HeadlinesNuveen Short Term Bond R6October 23, 2024 | morningstar.comMNuveen Short Term Bond ASeptember 18, 2024 | morningstar.comMBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of the market’s most overlooked opportunities today. NanoViricides, Inc. (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral now in human trials, with activity against COVID-19, RSV, influenza, measles, and most recently Mpox. With Phase II trials approved in Africa for the deadliest Mpox strain, the timing couldn’t be more critical.August 18 at 2:00 AM | Smallcaps Daily (Ad)TESHX Nuveen Short Term Bond Index Fund RetirementAugust 24, 2024 | seekingalpha.comTIBNX Nuveen International Bond Fund InstAugust 15, 2024 | seekingalpha.comReal estate stocks close a volatile week roughly flatAugust 10, 2024 | msn.comSee More Headlines NURE ETF - Frequently Asked Questions How have NURE shares performed this year? Nuveen Short-Term REIT ETF's stock was trading at $31.8008 on January 1st, 2025. Since then, NURE stock has decreased by 10.4% and is now trading at $28.5050. Who are Nuveen Short-Term REIT ETF's major shareholders? Top institutional investors of Nuveen Short-Term REIT ETF include Bank of America Corp DE (21.99%), KWB Wealth (1.78%), Stonehaven Wealth & Tax Solutions LLC (1.61%) and Tower Research Capital LLC TRC (1.56%). How do I buy shares of Nuveen Short-Term REIT ETF? Shares of NURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nuveen Short-Term REIT ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nuveen Short-Term REIT ETF investors own include Airbnb (ABNB), Advanced Micro Devices (AMD), Walt Disney (DIS), Marvell Technology (MRVL), NVIDIA (NVDA), Broadcom (AVGO) and Costco Wholesale (COST). Fund Details IssuerNuveen Fund NameNuveen Short-Term REIT ETF Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:NURE Inception Date12/19/2016 Fund ManagerPhilip James Campagna, Lei Liao WebN/A PhoneN/AFund Focus Asset ClassReal Estate BenchmarkDow Jones U.S. Select Short-Term REIT Index CategorySector FocusReal Estate Development LevelDeveloped Markets RegionNorth America Number of Holdings34 Fund Statistics Assets Under Management$34.40 million Average Daily Volume$4.02 thousand Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorBrown Brothers Harriman & Co. AdvisorNuveen Fund Advisors, LLC CustodianBrown Brothers Harriman & Co. DistributorNuveen Securities, LLC Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerLatour Trading Miscellaneous Outstanding Shares1,250,000Beta0.96 Creation Unit50,000 Creation Fee$500.00 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report Top 10 NURE HoldingsSun Communities (NYSE:SUI)Holding Weight: 5.27%Equity Lifestyle Properties (NYSE:ELS)Holding Weight: 5.17%American Homes 4 Rent (NYSE:AMH)Holding Weight: 5.06%Host Hotels & Resorts (NASDAQ:HST)Holding Weight: 5.06%Ryman Hospitality Properties (NYSE:RHP)Holding Weight: 5.06%Public Storage (NYSE:PSA)Holding Weight: 5.01%Mid-America Apartment Communities (NYSE:MAA)Holding Weight: 5.00%United Dominion Realty Trust (NYSE:UDR)Holding Weight: 4.94%Equity Residential (NYSE:EQR)Holding Weight: 4.88%Extra Space Storage (NYSE:EXR)Holding Weight: 4.87%Full Holdings DetailsNURE Sector ExposureNURE Industry Exposure This page (BATS:NURE) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuveen Short-Term REIT ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuveen Short-Term REIT ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access